Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Background: Voriconazole has an important role to play in the prophylaxis and management
of fungal endophthalmitis and keratitis. New-generation triazoles, including voriconazole …

Aspergillus species have emerged as an important cause of life-threatening infections in
immunocompromised patients. This expanding population is composed of patients with …

Invasive fungal infections (IFI) remain a leading cause of morbidity and mortality in
immunocompromised patients. This retrospective single-center study analyzed incidence …

As the population of patients with prolonged neutropenia, those receiving hematopoietic
stem cell transplantation or lung transplantation, or those with human immunodeficiency …

The prognosis for persons with invasive fungal infections has improved over the past 2
decades because of the development of new diagnostic tools, a better understanding of the …

Infections caused by yeasts and molds continue to be associated with high rates of morbidity
and mortality in both immunocompromised and immunocompetent patients. Many antifungal …

BACKGROUND Assessment of response to invasive aspergillosis (IA) therapy has been
challenging in treatment trials. METHODS The causes of death over 12 weeks were …

Fungal infections have historically been, and remain important causes of transplant-related
morbidity in recipients of hematopoietic stem cell transplant (HSCT). However, there have …

The prevalence of invasive fungal infections (IFIs) has increased over the past three
decades owing to the increasing numbers of immunocompromised hosts. These infections …